Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without renal dysfunction: a retrospective study.
Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H.
Drugs Aging. 2012 Feb 1;29(2):133-42. doi: 10.2165/11598440-000000000-00000.
Related citations
Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo.
Roelofs AJ, Stewart CA, Sun S, Błażewska KM, Kashemirov BA, McKenna CE, Russell RG, Rogers MJ, Lundy MW, Ebetino FH, Coxon FP.
J Bone Miner Res. 2012 Apr;27(4):835-47. doi: 10.1002/jbmr.1543.
Heritability of prevalent vertebral fracture and volumetric bone mineral density and geometry at the lumbar spine in three generations of the Framingham study.
Liu CT, Karasik D, Zhou Y, Hsu YH, Genant HK, Broe KE, Lang TF, Samelson EJ, Demissie S, Bouxsein ML, Cupples LA, Kiel DP.
J Bone Miner Res. 2012 Apr;27(4):954-8. doi: 10.1002/jbmr.1537.
Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives.
Baron R, Hesse E.
J Clin Endocrinol Metab. 2012 Feb;97(2):311-25. Epub 2012 Jan 11. Review.
Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland.
Lippuner K, Johansson H, Borgström F, Kanis JA, Rizzoli R.
Osteoporos Int. 2012 Jan 6. [Epub ahead of print]
Present at the beginning: a personal reminiscence on the history of teriparatide.
Marcus R.
Osteoporos Int. 2011 Aug;22(8):2241-8. Epub 2011 Mar 31.
New laboratory tools in the assessment of bone quality.
Chappard D, Baslé MF, Legrand E, Audran M.
Osteoporos Int. 2011 Aug;22(8):2225-40. Epub 2011 Feb 24. Review.
A review of patient-centred post-fracture interventions in the context of theories of health behaviour change.
Sujic R, Gignac MA, Cockerill R, Beaton DE.
Osteoporos Int. 2011 Aug;22(8):2213-24. Epub 2011 Jan 11. Review.
Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid.
Silverman SL, Kriegman A, Goncalves J, Kianifard F, Carlson T, Leary E.
Osteoporos Int. 2011 Aug;22(8):2337-45. Epub 2010 Nov 30.
Bone status in a mouse model of genetic hemochromatosis.
Guggenbuhl P, Fergelot P, Doyard M, Libouban H, Roth MP, Gallois Y, Chalès G, Loréal O, Chappard D.
Osteoporos Int. 2011 Aug;22(8):2313-9. Epub 2010 Oct 26.
Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys.
Saito M, Marumo K, Kida Y, Ushiku C, Kato S, Takao-Kawabata R, Kuroda T.
Osteoporos Int. 2011 Aug;22(8):2373-83. Epub 2010 Oct 20.
The 25(OH)D level needed to maintain a favorable bisphosphonate response is ≥33 ng/ml.
Carmel AS, Shieh A, Bang H, Bockman RS.
Osteoporos Int. 2012 Jan 12. [Epub ahead of print]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on